Rhythm

Published in:
Volume 1 / Year 2012 / Issue 1

Author(s):
Page: 48

Clinical biosimilar data should be accessible to all Calls are growing for biosimilar manufacturers to publish their data¬†in the public domain, particularly when developing versions of¬†monoclonal antibodies that are associated… Read More »

Go Back Print